Vice President, Health Economics & Market Access; HEMA), Vascular Therapies

Position: Vice President, Health Economics & Market Access (HEMA), Vascular Therapies
Diversity
- Innovation
- Caring
- Global Collaboration
- Winning Spirit
- High Performance At Boston Scientific, we’ll give you the opportunity to harness all that’s within you by working in teams of diverse and high-performing employees, tackling some of the most important health industry challenges. With access to the latest tools, information and training, we’ll help you in advancing your skills and career. Here, you’ll be supported in progressing – whatever your ambitions.

About the Role:

Boston Scientific is seeking a strategic leader to serve as Vice President, Health Economics & Market Access (HEMA) for Vascular Therapies. As a member of the VT Leadership Team, this senior leader will define and lead the global HEMA strategy, ensuring market access, reimbursement, health economics, evidence generation, and value communication are integrated across portfolio strategy, product development, commercialization, and lifecycle management.

The Vice President will partner across global, regional, and functional teams to expand patient access, support technology adoption, demonstrate value, and drive sustainable business growth. This leader will also build and develop a high-performing global HEMA organization while shaping future market access capabilities across the franchise.

Your Responsibilities Will Include:

Global HEMA Strategy and Business Leadership Define and lead the global HEMA vision and strategy for the Vascular Therapies portfolio, aligned with business objectives and growth priorities.

Serve as a strategic member of the Vascular Therapies leadership team, advising on market access, reimbursement, health policy, and economic trends.

Establish HEMA priorities, investments, and measures of success to support patient access and commercial performance.

Drive alignment and execution of HEMA strategies across Vascular Therapies and the broader enterprise.

Portfolio and Product Strategy Integrate market access, reimbursement, health economics, and evidence strategies into portfolio planning, product development, commercialization, and lifecycle management.

Lead global HEMA strategies for new and existing products, including coverage, coding, payment, evidence generation, and value communication.

Partner cross-functionally to identify opportunities, mitigate risks, and support product launches, indication expansions, and business development activities.

Ensure market access considerations inform portfolio prioritization and investment decisions.

Reimbursement and Market Access Lead global market access strategies that support coverage, coding, payment, and adoption of Vascular Therapies technologies.

Provide expertise in global reimbursement environments, payer expectations, health technology assessment, and U.S. healthcare policy.

Partner with regional teams to ensure strategies address local market needs while maintaining global alignment.

Engage external stakeholders, including payers, providers, policymakers, and professional societies, to advance patient access and reimbursement objectives.

Health Economics, Evidence, and Value Communication Establish evidence-generation and health economics priorities that demonstrate the clinical, economic, and healthcare system value of Vascular Therapies technologies.

Partner with Clinical, Medical Affairs, and other functions to develop evidence strategies that address payer, provider, and policy needs.

Oversee the development of economic analyses, real-world evidence, value propositions, reimbursement resources, and customer value tools.

Translate complex health economic and market access insights into actionable business recommendations and compelling value communications.

Commercialization and Customer Partnership Partner with regional, field, and…